Spatially organized inflammatory myeloid-CD8+ T cell aggregates linked to Merkel-cell Polyomavirus driven Reorganization of the Tumor Microenvironment
Single-cell RNA-seq · human · 146 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Topic
- Merkel cell carcinomaThis series is part of our curated briefing on it.
- Samples
- 146 samples: 146 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281260_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1182821 and SRA study SRP543647. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 146 sample titles: 146 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8615684 TMA1, cap10, PtID25, viruspositive, response0, treatmentpre, LocalDisease1, Metastasis1, Survival0
- GSM8615685 TMA1, cap11, PtID57, virusnegative, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615686 TMA1, cap12, PtID76, viruspositive, response0, treatmentpre, LocalDisease1, Metastasis1, Survival1
- GSM8615687 TMA1, cap13, PtID66, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615688 TMA1, cap14, PtID65, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615689 TMA1, cap15, PtID65, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615690 TMA1, cap16, PtID61, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis1, Survival0
- GSM8615691 TMA1, cap17, PtID60, viruspositive, responseNA, treatmentFU, LocalDisease1, Metastasis1, Survival0
- GSM8615692 TMA1, cap18, PtID8, viruspositive, response0, treatmentpost, LocalDisease0, Metastasis1, Survival1
- GSM8615693 TMA1, cap19, PtID8, viruspositive, response0, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615694 TMA1, cap1, PtID51, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615695 TMA1, cap21, PtID5, viruspositive, response0, treatmentpost, LocalDisease0, Metastasis1, Survival0
- GSM8615696 TMA1, cap22, PtID5, viruspositive, response0, treatmentpre, LocalDisease0, Metastasis1, Survival0
- GSM8615697 TMA1, cap23, PtID4, viruspositive, response1, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615698 TMA1, cap24, PtID2, virusnegative, response0, treatmentpre, LocalDisease1, Metastasis1, Survival1
- GSM8615699 TMA1, cap25, PtID15, virusnegative, response1, treatmentpost, LocalDisease1, Metastasis1, Survival0
- GSM8615700 TMA1, cap26, PtID15, virusnegative, response1, treatmentpre, LocalDisease1, Metastasis1, Survival0
- GSM8615701 TMA1, cap27, PtID10, viruspositive, response1, treatmentpre, LocalDisease0, Metastasis1, Survival0
- GSM8615702 TMA1, cap28, PtID9, virusnegative, response0, treatmentFU, LocalDisease1, Metastasis1, Survival1
- GSM8615703 TMA1, cap29, PtID9, virusnegative, response0, treatmentpre, LocalDisease1, Metastasis1, Survival1
- GSM8615704 TMA1, cap2, PtID26, viruspositive, response1, treatmentpre, LocalDisease0, Metastasis1, Survival0
- GSM8615705 TMA1, cap30, PtID58, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615706 TMA1, cap31, PtID27, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615707 TMA1, cap32, PtID78, virusnegative, response1, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615708 TMA1, cap33, PtID52, virusnegative, response0, treatmentpre, LocalDisease1, Metastasis1, Survival0
- GSM8615709 TMA1, cap34, PtID35, virusnegative, response1, treatmentpre, LocalDisease1, Metastasis1, Survival1
- GSM8615710 TMA1, cap35, PtID59, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615711 TMA1, cap36, PtID39, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615712 TMA1, cap37, PtID32, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615713 TMA1, cap38, PtID31, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615714 TMA1, cap39, PtID25, viruspositive, response0, treatmentFU, LocalDisease1, Metastasis1, Survival0
- GSM8615715 TMA1, cap3, PtID21, viruspositive, responseNA, treatmentpre, LocalDisease1, Metastasis0, Survival0
- GSM8615716 TMA1, cap40, PtID64, viruspositive, responseNA, treatmentpost, LocalDisease0, Metastasis1, Survival1
- GSM8615717 TMA1, cap41, PtID64, viruspositive, responseNA, treatmentFU, LocalDisease0, Metastasis1, Survival1
- GSM8615718 TMA1, cap42, PtID64, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis1, Survival1
- GSM8615719 TMA1, cap43, PtID63, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615720 TMA1, cap44, PtID62, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615721 TMA1, cap45, PtID23, viruspositive, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615722 TMA1, cap46, PtID20, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
- GSM8615723 TMA1, cap47, PtID77, virusnegative, responseNA, treatmentpre, LocalDisease0, Metastasis0, Survival0
+ 106 more — browse all 146 samples with per-sample file links →
- GSE229019 Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling [RNA-Seq] 28 samples same disease briefing · shares polyomavirus
- GSE278335 Host response to Merkel cell polyomavirus oncogenes in neonatal human dermal fibroblast 18 samples same disease briefing · shares polyomavirus
- GSE273479 Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway 6 samples same disease briefing · shares polyomavirus
- GSE254170 Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1 3 samples same disease briefing · shares polyomavirus
- GSE235093 Pre-existing skin-resident CD8 and γδ T cell circuits mediate immune response in Merkel cell carcinoma and Predict immunotherapy efficacy 333 samples same disease briefing
- GSE292992 MDM2 degradation overcomes feedback regulation of p53 signaling in Merkel cell carcinoma 66 samples same disease briefing
- GSE317774 ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING 48 samples same disease briefing
- GSE154938 Glucose-6-Phosphate Dehydrogenase as a Prognostic Predictor Correlates with the Tumor Immune Activity Including Programmed Death Ligand-1 Expression in Merkel Cell Carcinoma 41 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.